Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
U0126-EtOH
Cat. No.:
OB0225LY-0401
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
U0126-EtOH is a MEK inhibitor commonly used to study the regulation of the ERK signaling pathway.
Synonym:
U0126 Ethanol; U0126; 1173097-76-1; (2Z,3Z)-2,3-Bis[amino-(2-aminophenyl)sulfanylmethylidene]butanedinitrile ethanol; (2Z,3Z)-2,3-Bis(amino(2-aminophenylthio)methylene)succinonitrile compound with ethanol (1:1); 2,3-Bis(amino((2-aminophenyl)thio)methylene)succinonitrile compound with ethanol (1:1)
CAS No.:
1173097-76-1
Compound CID:
16220066
Formula:
C18H16N6S2·C2H6O
Formula Weight:
426.6
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
U0126-EtOH can be used for the study of cell proliferation and differentiation mechanisms or play an important role in cancer research.
Library Information
Targets:
MEK
Receptors:
MEK1; MEK2
Pathways:
Autophagy; MAPK; Microbiology/Virology
Plate Number:
AOCL-6
Plate Location:
b7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 128.93 mM
Ethanol Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Solubility:
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 7.9 mg/mL (18.52 mM)
